Cabinet approves first drug under new process

Ibrutinib is used to treat patients with a common form of leukaemia

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
12th June, 2016
Ibrutinib has been the first drug to be approved

The cabinet approved its first medicine under the state’s new drug approval process this week.

Ibrutinib, which is used to treat patients with a common form of leukaemia, is manufactured by Janssen and marketed as Imbruvica.

As the medicine exceeded a certain cost threshold the final decision on its approval had to be made by Minister for Health Simon Harris and his cabinet colleagues.

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Children prescribed adult doses of drugs at Kerry mental health centre

Health Róisín Burke 19 hours ago

Patients with rare diseases urge Dáil to pass law on orphan drugs

Health Daniel Murray 2 days ago

Contractor’s claims against children’s hospital could add €446m to project

Health Donal MacNamee 1 week ago

Spunout.ie to relaunch with new look